Lucis
Your body has the answers. Lucis helps you reveal them.
Paris, France · Founded 2025 · $28.5M raised
- Headquarters
- Paris
- Employees
- 11–50
- Founded
- 2025
- Business Model
- B2C
- Website
- lucis.life
- Total Funding
- $28.5M
- Last Round
- $20.0M Series AMay 2026
- Rounds
- 2
About
Lucis turns comprehensive blood tests into personalized insights and action plans via AI-driven analysis of 100+ biomarkers, enabling Europeans to monitor their health twice yearly and build evidence-based lifestyle changes across nutrition, sleep, physical activity, and mental health.
Summary
Lucis is a Life Sciences company based in Paris, France, founded in 2025. It has raised $28.5M in total across 2 rounds, most recently a $20.0M Series A round in May 2026. Investors include General Catalyst, Singular and Kima Ventures.
Tech & App Stack
7 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2026
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...